Boehringer-Zealand's obesity drug shows promise in cutting visceral, liver fat Boehringer Ingelheim said on Sunday its experimental obesity drug cut visceral and liver fat while minimizing loss of ...
This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. The above button links to ...
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results